Organophosphorus-Induced Delayed Neuropathy

Hayes' Handbook of Pesticide Toxicology

Volumn , Issue , 2010, Pages 1479-1504

  Ehrich, Marion ^a   Jortner, Bernard S ^a  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882783436     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374367-1.00069-0     Document Type: Chapter

References (244)

1. Abou-Donia M.B. Organophosphorus ester-induced delayed neurotoxicity. Annu. Rev. Pharmacol. Toxicol. 1981, 21:511-548.
2. Abou-Donia M.B. The cytoskeleton as a target for organophosphorus ester-induced delayed neurotoxicity (OPIDN). Chem. Biol. Interact. 1993, 87:383-393.
3. Abou-Donia M.B. Organophosphorus pesticides. Handbook of Toxicology 1995, 419-473. Dekker, New York. L.W. Chang, R.S. Dyer (Eds.).
4. Abou-Donia M.B. Organophosphorus ester-induced chronic neurotoxicity. Arch. Environ. Health 2003, 58:484-497.
5. Abou-Donia M.B., Graham D.G. Delayed neurotoxicity from long-term low-level topical administration of leptophos to the comb of hens. Toxicol. Appl. Pharmacol. 1978, 46:199-213.
6. Abou-Donia M.B., Lapadula D.M. Mechanisms of organophosphorus ester-induced delayed neurotoxicity: Type I and type II. Annu. Rev. Pharmacol. Toxicol. 1990, 30:405-440.
7. Abou-Donia M.B., Preissig S.H. Delayed neurotoxicity of leptophos: Toxic effects on the nervous system of hens. Toxicol. Appl. Pharmacol. 1976, 35:269-282.
8. Abou-Donia M.B., Preissig S.H. Delayed neurotoxicity from continuous low-dose oral administration of leptophos to hens. Toxicol. Appl. Pharmacol. 1976, 38:595-608.
9. Abou-Donia M.B., Graham D.G., Komeil A.A. Delayed neurotoxicity of O-ethyl O-2,4-dichlorophenyl phenylphosphonothioate: Effects of a single oral dose on hens. Toxicol. Appl. Pharmacol. 1979, 49:293-303.
10. Abou-Donia M.B., Trofatter L.P., Graham D.G., Lapadula D.M. Electromyographic, neuropathologic, and functional correlates in the cat as the result of tri-O-cresyl phosphate delayed neurotoxicity. Toxicol. Appl. Pharmacol. 1986, 83:126-141.
11. Akassoglou K., Malester B., Xu J., Tessarollo L., Rosenbluth J., Chao M.V. Brain-specific deletion of neuropathy target esterase/swisscheese results in neurodegeneration. Proc. Natl. Acad. Sci. USA 2004, 101:5075-5080.
12. Anderson R.J., Robertson D.G., Henderson J.D., Wilson B.W. DFP-induced elevation of strength-duration threshold in hen peripheral nerve. Neurotoxicology 1988, 9:47-52.
13. Baker T., Stanec A. Methylprednisolone treatment of an organophosphorus-induced delayed neuropathy. Toxicol. Appl. Pharmacol. 1985, 79:348-352.
14. Baker T., Lowndes H.E., Johnson M.K., Sandborg R.C. The effects of phenlymethanesulfonyl fluoride on delayed organophosphorus neuropathy. Arch. Toxicol. 1980, 46:305-311.
15. Baker T., Drakontides A.B., Riker W.F. Prevention of the organophosphorus neuropathy by glucocorticoids. Exp. Neurol. 1982, 78:397-408.
16. Barber D.S., Ehrich M. Esterase inhibition in SH-SY5Y human neuroblastoma cells following exposure to organophosphorus compounds for 28 days. In Vitro Mol. Toxicol. 2001, 14:129-135.
17. Barber D., Correll L., Ehrich M. Comparison of two in vitro activation systems for protoxicant organophosphorus esterase inhibitors. Toxicol. Sci. 1999, 47:16-22.
18. Barber D., Correll L., Ehrich M. Comparative effectiveness of organophosphorus protoxicant activating systems in neuroblastoma cells and brain homogenates. J. Toxicol. Environ. Health 1999, 56:101-112.
19. Battershill J.M., Edwards P.M., Johnson M.K. Toxicological assessment of isomeric pesticides: A strategy for testing of chiral organophosphorus (OP) compounds for delayed polyneuropathy in a regulatory setting. Food Chem. Toxicol. 2004, 42:1279-1285.
20. Beck B.E., Wood C.D., Whanham G.R. Triaryl phosphate poisoning in cattle. Vet. Pathol. 1977, 14:128-137.
21. Bertoncin D., Russolo A., Caroldi S., Lotti M. Neuropathy target esterase in human lymphocytes. Arch. Environ. Health 1985, 40:139-144.
22. Bettencourt da Cruz A., Wentzell J., Kretzschmar D. Swiss cheese, a protein involved in progressive neurodegenerations, acts as a noncanonical regulatory subunit for PKA-C3. J. Neurosci. 2008, 28:10885-10892.
23. Bischoff A. The ultrastructure of tri-ortho-cresyl phosphate poisoning: I. Studies on myelin and axonal alterations in the sciatic nerve. Acta Neuropathol. 1967, 9:158-174.
24. Bischoff A. Ultrastructure of tri-ortho-cresyl phosphate poisoning in the chicken: II. Studies on spinal cord alterations. Acta Neuropathol. 1970, 15:142-155.
25. Borhan B., Ko Y., Mackay C., Wilson B.W., Kurth M.J., Hammock B.D. Development of surrogate substrates for neuropathy target esterase. Biochim. Biophys. Acta 1995, 1250:171-182.
26. Bouldin T.W., Cavanagh J.B. Organophosphorus neuropathy: I. A teased-fiber study of the spatio-temporal spread of axonal degeneration. Am. J. Pathol. 1979, 94:241-252.
27. Bouldin T.W., Cavanagh J.B. Organophosphorus neuropathy: II. A fine-structural study of the early stages of axonal degeneration. Am. J. Pathol. 1979, 94:253-270.
28. Brailowsky S. Therapeutic approaches in subjects with brain lesions. Pharmacological Approaches to the Treatment of Brain and Spinal Cord Injury 1988, 1-21. Plenum, New York. D.G. Stein, B.A. Sabel (Eds.).
29. Bursian S.J., Lehning E.J., Correll L., Enrich M. Effect of beta-naphthoflavone on o-tolyl saligenin phosphate-induced delayed neuropathy in two lines of chickens. J. Toxicol. Environ. Health 1989, 28:461-471.
30. Capildeo R. Steroids in Diseases of the Central Nervous System 1989, Wiley, New York.
31. Carboni D., Ehrich M., Dyer K., Jortner B.S. Comparative evolution of mipafox-induced delayed neuropathy in rats and hens. Neurotoxicology 1992, 13:723-733.
32. Carlson K., Ehrich M. Organophosphorus compound-induced modification of SH-SY5Y human neuroblastoma mitochondrial transmembrane potential. Toxicol. Appl. Pharmacol. 1999, 160:33-42.
33. Carlson K., Ehrich M. Organophosphorus compounds alter intracellular F-actin content in SH-SY5Y human neuroblastoma cells. Neurotoxicology 2001, 22:819-827.
34. Carlson K., Ehrich M. Organophosphorus compound-induced delayed neurotoxicity in White Leghorn hens assessed by Fluoro-Jade. Int. J. Toxicol. 2004, 23:259-266.
35. 3H]diisopropyl phosphorofluoridate-binding proteins in hen brain: Rates of phosphorylation and sensitivity to neurotoxic and non-neurotoxic organophosphorus compounds. Biochem. J. 1985, 228:537-544.
36. Carrington C.D., Brown H.R., Abou-Donia M.B. Histopathological assessment of triphenyl phosphate neurotoxicity in the hen. Neurotoxicology 1988, 9:223-233.
37. Carrington C.D., Lapadula D.M., Abou-Donia M.B. Acceleration of anterograde axonal transport in cat sciatic nerve by diisopropyl phosphorofluoridate. Brain Res. 1989, 476:179-182.
38. Casida J.E., Quistad G.B. Serine hydrolase targets of organophosphorus toxicants. Chem. Biol. Interact. 2005, 157-158:277-283.
39. Casida J.E., Nomura D.K., Vose S.C., Fujioka K. Organophosphate-sensitive lipases modulate brain lysophospholipids, ether lipids and endocannabinoids. Chem. Biol. Interact. 2008, 175:355-364.
40. Cavalleri A., Cosi V. Polyneuropathy in shoe factory workers. Advances in Neurotoxicology 1980, 193-200. Pergamon, New York. L. Manzo (Ed.).
41. Cavanagh J.B. The toxic effects of tri-ortho-cresyl phosphate on the nervous system: An experimental study in hens. J. Neurol. Neurosurg. Psychiatr. 1954, 17:163-172.
42. Cavanagh J.B. Peripheral nerve changes in ortho-cresyl phosphate poisoning in the cat. J. Pathol. Bacteriol. 1964, 87:365-383.
43. Cavanagh J.B., Patangia G.N. Changes in the central nervous system in the cat as the result of tri-o-cresyl phosphate poisoning. Brain 1965, 88:165-180.
44. Chang P.A., Chen R., Wu Y.J. Reduction of neuropathy target esterase does not affect neuronal differentiation, but moderate expression induces neuronal differentiation in human neuroblastoma (SK-N-SH) cell line. Brain Res. 2005, 141:30-38.
45. Chang P.A., Wu Y.J., Li W., Leng X.F. Effect of carbamate esters in SK-N-SH neuroblastoma cells. Chem. Biol. Interact. 2006, 169:65-72.
46. Chang P.A., Long D.X., Sun Q., Wang Q., Bu Y.Q., Wu Y.J. Identification and characterization of a splice variant of the catalytic domain of mouse NTE-related esterase. Gene 2008, 417:43-50.
47. Chang P.A., Sun Q., Ni X.M., Qv F.Q., Wu Y.J., Song R.Z. Molecular cloning and expression analysis of cDNA ends of chicken neuropathy target esterase. Chem. Biol. Interact. 2008, 172:54-62.
48. Chemnitius J.M., Holling M., Meyer J.H., Schmidt P.F., Schomburg E.D., Steffens H., Zech R. Influence of the organophosphorus compound DFP on inhibitory motor systems and esterase activity in the spinal cord of cats. Neurosci. Res. 1988, 6:257-263.
49. Cherniack M.G. Organophosphorus esters and polyneuropathy. Ann. Int. Med 1986, 104:264-266.
50. Cherniack M.G. Toxicological screening for organophosphorus-induced delayed neurotoxicity: Complications in toxicity testing. Neurotoxicology 1988, 9:249-272.
51. Cho T., Tiffany-Castiglioni E. Neurofilament 200 as an indicator of differences between mipafox and paraoxon sensitivity in SY5Y neuroblastoma cells. J. Toxicol. Environ. Health 2004, 67A:987-1000.
52. Classen W., Gretener P., Rauch M., Weber E., Krinke G.J. Susceptibility of various areas of the nervous system of hens to TOCP-induced delayed neuropathy. Neurotoxicology 1996, 17:597-604.
53. Costa L.G. Toxic effects of pesticides. Casarett & Doull's Toxicology the Basic Science of Poisons 2008, 883-930. McGraw-Hill, New York. 7th ed. C.D. Klaassen (Ed.).
54. Damodaran T.V., Abou-Donia M.B. Alterations in levels of mRNAs coding for glial fibrilliary acidic protein (GFAP) and vimentin genes in the central nervous system of hens treated with diisopropyl phosphorofluoridate (DFP). Neurochem. Res. 2000, 25:809-819.
55. Damodaran T.V., Abdel-Rahman A., Abou-Donia M.B. Altered time course of mRNA expression of alpha tubulin in the central nervous system of hens treated with diisopropyl phosphorofluoridate (DFP). Neurochem. Res. 2001, 26:43-50.
56. Das K.P., Barone S. Neuronal differentiation in PC12 cells is inhibited by chlorpyrifos and its metabolites: Is acetylcholinesterase inhibition the site of action?. Toxicol. Appl. Pharmacol 1999, 160:217-230.
57. Drakontides A.B., Baker T. An electrophysiologic and ultra-structural study of the phenylmethanesulfonyl fluoride protection against a delayed organophosphorus neuropathy. Toxicol. Appl. Pharmacol. 1983, 70:411-422.
58. Drakontides A.B., Baker W., Riker W.F. A morphological study of the effect of glucocorticoid treatment on delayed organophosphorus neuropathy. Neurotoxicology 1982, 3:165-178.
59. Dretchen K.L., Bowles A.M., Raines A. Protection by phenytoin and calcium channel blocking agents against the toxicity of diisopropylfluorophosphate. Toxicol. Appl. Pharmacol. 1986, 83:584-589.
60. Dunnington E.A., Siegel P.B., Ehrich M. Differences in response of chickens from two genetic lines to diisopropyl phosphorofluoridate. Neurotoxicology 1989, 10:71-78.
61. Durham H.D., Ecobichon D.J. The function of motor nerves innervating slow tonic skeletal muscle in hens with delayed neuropathy induced by tri-o-tolyl phosphate. Can. J. Physiol. Pharmacol. 1984, 62:1268-1273.
62. Dyer K., Ehrich M., Jortner B.S. Neuropathology of organophosphorus ester induced delayed neuropathy (OPIDN) in hens, lesions of spinal cord gray matter revisited. Fundam. Appl. Toxicol. 1996, 30S:300.
63. Dyer K.R., El-Fawal H.A., Ehrich M.F. Comparison of organophosphate-induced delayed neuropathy between branches of the tibial nerve and the biventer cervicis nerve in chickens. Neurotoxicology 1991, 12:687-695.
64. Dyer K.R., Jortner B.S., Shell L.G., Ehrich M. Comparative dose-response studies of organophosphorus ester-induced delayed neuropathy in rats and hens administered mipafox. Neurotoxicology 1992, 13:745-755.
65. Ecobichon D.J. Organophosphorus insecticides. Pesticides and Neurological Diseases 1994, 171-249. CRC Press, Boca Raton, FL. D.J. Ecobichon, R.M. Joy (Eds.).
66. Ehrich, M. (1996). Neurotoxic esterase inhibition: Predictor of potential for organophosphorus-induced delayed neuropathy. In "Biomarkers for Agrochemicals and Toxic Substances" (J. N. Blancato, R. N. Brown, C. C. Dary and M. A. Saleh, eds.), pp. 79-93. Am. Chem. Soc, Washington, DC.
67. Ehrich M., Dorman D.C. Predictive value of in vitro systems for neurotoxicity risk assessment. Methods in Pharmacology and Toxicology: In Vitro Neurotoxicology: Principles and Challenges 2004, 29-40. Human Press, Totowa, NJ. E. Tiffany-Castiglioni, (Ed.).
68. Ehrich M., Gross W.B. Effect of corticosterone on toxicity of malathion and TOTP in hens. Neurobehav. Toxicol. Teratol. 1982, 4:789-792.
69. Ehrich M., Gross W.B. Modification of tri-ortho-tolyl phosphate toxicity in chickens by stress. Toxicol. Appl. Pharmacol. 1983, 70:249-254.
70. Ehrich M., Jortner B.S. Organophosphorus-induced delayed neuropathy. Handbook of Pesticide Toxicology 2001, 987-1012. Academic Press, San Diego. R. Krieger, (Ed.).
71. Ehrich M., Veronesi B. In vitro neurotoxicology. Neurotoxicology 1999, 37-51. Taylor & Francis, Philadelphia. 2nd ed. H.A. Tilson, G.J. Harry (Eds.).
72. Ehrich M., Jortner B.S., Gross W.B. Absence of a protective effect of corticosterone on O,O-diisopropyl phosphorofluoridate (DFP) induced delayed neurotoxicity in chickens. Neurotoxicology 1985, 6:87-92.
73. Ehrich M., Briles R.W., Briles W.E., Dunnington E.A., Martin A., Siegel P.B., Gross W.B. Neurotoxicity of tri-ortho-tolyl phosphate in chickens of different genotypes in the presence and absence of deoxycorticosterone. Poultry Sci. 1986, 65:375-379.
74. Ehrich M., Jortner B.S., Gross W.B. Dose-related beneficial and adverse effects of dietary corticosterone on organophosphorus-induced delayed neuropathy in chickens. Toxicol. Appl. Pharmacol. 1986, 83:250-260.
75. Ehrich M., Jortner B.S., Gross W.B. Types of adrenocorticoids and their effect on organophosphorus-induced delayed neuropathy in chickens. Toxicol. Appl. Pharmacol. 1988, 92:214-223.
76. Ehrich M., Jortner B.S., Padilla S. Comparison of the relative inhibition of acetylcholinesterase and neuropathy target esterase in rats and hens given cholinesterase inhibitors. Fundam. Appl. Toxicol. 1995, 24:94-101.
77. Ehrich M., Correll L., Veronesi B. Acetylcholinesterase and neuropathy target esterase inhibitions in neuroblastoma cells to distinguish organophosphorus compounds causing acute and delayed neurotoxicity. Fundam. Appl. Toxicol. 1997, 38:55-63.
78. Ehrich M., Hancock S., Ward D., Holladay S., Pung T., Flory L., Hinckley J., Jortner B.S. Neurologic and immunologic effects of exposure to corticosterone, chlorpyrifos, and multiple doses of tri-ortho-tolyl phosphate over a 28-day period in rats. J. Toxicol. Environ. Health 2004, 67A:431-457.
79. El-Fawal H.A., Ehrich M.F. Calpain activity in organophosphorus-induced delayed neuropathy (OPIDN): Effects of a phenylalkylamine calcium channel blocker. Ann. N. Y. Acad. Sci. 1993, 679:325-329.
80. El-Fawal H.S., McCain W.C. Antibodies to neural proteins in organophosphorus-induced delayed neuropathy (OPIDN) and its amelioration. Neurotoxicol. Teratol. 2008, 30:161-166.
81. El-Fawal H.A., Jortner B.S., Eyre P., Ehrich M. The biventer cervicis nerve-muscle preparation of adult hens: Effects of phenyl saligenin phosphate administration. Neurotoxicology 1988, 9:625-636.
82. El-Fawal H.A., Jortner B.S., Ehrich M. Effect of verapamil on organophosphorus-induced delayed neuropathy in hens. Toxicol. Appl. Pharmacol. 1989, 97:500-511.
83. El-Fawal H.A., Correll L., Gay L., Ehrich M. Protease activity in brain, nerve, and muscle of hens given neuropathy-inducing organophosphates and a calcium channel blocker. Toxicol. Appl. Pharmacol. 1990, 103:133-142.
84. El-Fawal H.A., Jortner B.S., Ehrich M. Modification of phenyl saligenin phosphate-induced delayed effects by calcium channel blockers: In vivo and in vitro electrophysiological assessment. Neurotoxicology 1990, 11:573-592.
85. El-Fawal H.A., Jortner B.S., Ehrich M. Use of the biventer cervicis nerve-muscle preparation to detect early changes following exposure to organophosphates inducing delayed neuropathy. Fundam. Appl. Toxicol. 1990, 15:108-120.
86. El-Sebae A.H., Soliman S.A., Abo El-Amayen M., Ahmed N.S. Neurotoxicity of organophosphorus insecticides leptophos and EPN. J. Environ. Sci. Health B 1977, 12:269-288.
87. Fox J.H., Jortner B.S., Barber D., Ehrich M.F. Altered expression of transcripts for a-tubulin and an unidentified gene in the spinal cord of phenyl saligenin phosphate treated hens (Gallus gallus). J. Biochem. Mol. Toxicol. 2003, 27:263-271.
88. Funk K.A., Henderson J.D., Liu C.H., Higgins R.J., Wilson B.W. Neuropathology of organophosphate-induced delayed neuropathy (OPIDN) in young chicks. Arch. Toxicol. 1994, 68:308-316.
89. Funk K.A., Liu C.H., Higgins R.J., Wilson B.W. Avian embryonic brain reaggregate culture system: II. NTE activity discriminates between effects of a single neuropathic or nonneuropathic organophosphorus compound exposure. Toxicol. Appl. Pharmacol. 1994, 124:159-163.
90. Funk K.A., Liu C.H., Wilson B.W., Higgins R.J. Avian embryonic brain reaggregate culture system: I. Characterization for organophosphorus compound toxicity studies. Toxicol. Appl. Pharmacol. 1994, 124:149-158.
91. Gallo M.A., Lawryk N.J. Organic phosphorus pesticides. "Handbook of Pesticide Toxicology" 1991, Vol. 2:917-1123. Academic Press, San Diego. W.J. Hayes, E.R.J. Laws (Eds.).
92. Gardiman G., Moretto A., Lotti M. Influence of dithiocarbamates on the development of organophosphate induced delayed polyneuropathy (OPIDP). Toxicol. Sci. 1999, 48S:100.
93. Glazer E.J., Baker T., Riker W.F. The neuropathology of DFP at cat soleus neuromuscular junction. J. Neurocytol. 1978, 7:741-758.
94. Glynn P. Neuropathy target esterase and phospholipid deacylation. Biochim. Biophys. Acta 2005, 1736:87-93.
95. Glynn P. A mechanism for organophosphate-induced delayed neuropathy. Toxicol. Lett. 2006, 162:94-97.
96. Glynn P. Axonal degeneration and neuropathy target esterase. Arh. Hig. Rada Toksikol. 2007, 48:355-358.
97. 3H]DFP-labelled polypeptide. Chem. Biol. Interact. 1993, 87:361-367.
98. Glynn P., Read D.J., Quo R., Wylie S., Johnson M.K. Synthesis and characterization of a biotinylated organophosphorus ester for detection and affinity purification of a brain serine esterase: Neuropathy target esterase. Biochem. J. 1994, 301:551-556.
99. Glynn P., Hotton J.L., Nolan C.C., Read D.J., Brown L., Hubbard A., Cavanagh J.B. Neuropathy target esterase: Immunolocalization to neuronal cell bodies and axons. Neuroscience 1998, 83:295-302.
100. Glynn P., Read D.J., Lush M.J., Li Y., Atkins J. Molecular cloning of neuropathy target esterase (NTE). Chem. Biol. Interact. 1999, 119-120:513-518.
101. Gupta R.P., Abou-Donia M.B. In vivo and in vitro effects of diisopropyl phosphorofluoridate (DFP) on the rate of hen brain tubulin polymerization. Neurochem. Res. 1994, 19:435-444.
102. Gupta R.P., Abou-Donia M.B. Diisopropyl phosphorofluoridate (DFP) treatment alters calcium-activated proteinase activity and cytoskeletal proteins of the hen sciatic nerve. Brain Res. 1995, 677:162-166.
103. 2+/calmodulin-dependent protein kinase in the brain subcellular fractions of diisopropyl phosphorofluoridate (DFP)-treated hen. Neurochem. Res. 1995, 20:1095-1105.
104. Gupta R.P., Abdel-Rahman A., Wilmarth K.W., Abou-Donia M.B. Alteration in neurofilament axonal transport in the sciatic nerve of the diisopropyl phosphorofluoridate (DFP)-treated hen. Biochem. Pharmacol. 1997, 53:1799-1806.
105. Gupta R.P., Lin W.W., Abou-Donia M.B. Enhanced mRNA expression of neurofilament subunits in the brain and spinal cord of diisopropyl phosphorofluoridate-treated hens. Biochem. Pharmacol. 1999, 57:1245-1251.
106. Haley R.W., Horn J., Roland P.S., Bryan W.W., Van Ness P.C., Bonte F.J., Devous M.D., Mathews D., Fleckenstein J.L., Wians F.H., Wolfe G.I., Kurt T.L. Evaluation of neurologic function in Gulf War veterans. J. Am. Med. Assoc. 1997, 277:223-230.
107. Hargreaves A.J., Fowler M.J., Sachana M., Flaskos J., Bountouri M., Coutts J.C., Glynn P., Harris W., Graham McLean W. Inhibition of neurite outgrowth in differentiating mouse N2a neuroblastoma cells by phenyl saligenin phosphate: effects on MAP kinase (ERK 1/2) activation, neurofilament heavy chain phosphorylation and neuropathy target esterase activity. Biochem. Pharmacol. 2006, 71:1240-1247.
108. Harp P., Tanaka D., Pope C.N. Potentiation of organophosphorus-induced delayed neurotoxicity following phenyl saligenin phosphate exposures in 2-, 5-, and 8-week-old chickens. Fundam. Appl. Toxicol. 1997, 37:64-70.
109. Hollingshaus J.G. Chemistry and metabolism of delayed neurotoxic organophosphorus esters. "14th Conference on Environmental Toxicology," 1983, 76-105. National Technical Information Service, Springfield, VA.
110. Hong M.S., Hong S.J., Barhoumi R., Burghardt R.C., Donnelly K.C., Wild J.R., Venkatraj V., Tiffany-Castiglioni E. Neurotoxicity induced in differentiated SK-N-SH-SY5Y human neuroblastoma cells by organophosphorus compounds. Toxicol. Appl. Pharmacol. 2003, 186:110-118.
111. Hou W.Y., Long D.X., Wang H.P., Wang Q., Wu Y.J. The homeostasis of phosphatidylcholine and lysophosphatidylcholine was not disrupted during tri-o-cresyl phosphate-induced delayed neurotoxicity in hens. Toxicology 2008, 252:56-63.
112. Hou W.Y., Long D.X., Wu Y.J. The homeostasis of phosphatidylcholine and lysophosphatidylcholine in nervous tissues of mice was not disrupted after administration of tri-o-cresyl phosphate. Toxicol. Sci. 2009, 109:276-285.
113. Illis L., Pantangia G.N., Cavanagh J.B. Boutons terminaux and tri-ortho-cresyl phosphate neurotoxicity. Exp. Neurol. 1966, 14:160-174.
114. Gulf War and Health: Vol. 1 Depleted Uranium, Pyridostigmine, Bromide, Sarin, Vaccines 2001, Institute of Medicine, National Academy of Sciences, Washington, DC.
115. Neurological effects. "Gulf War and Health: Vol. 2 Insecticides and Solvents," 2003, 353-459. Institute of Medicine, National Academy of Sciences, Washington, DC.
116. Gulf War and Health Update Literature Review of Sarin 2004, Institute of Medicine, National Academy of Sciences, Washington, DC.
117. Inui K., Mitsumori K., Harada T., Maita K. Quantitative analysis of a neuronal damage induced by tri-ortho-cresyl phosphate in Wistar rats. Fundam. Appl. Toxicol. 1993, 20:111-119.
118. Itoh H., Kishida H., Tadokoro M., Oikawa K. Studies on the delayed neurotoxicity of organophosphorus compounds. II. J. Toxicol. Sci. 1984, 9:37-50.
119. Itoh H., Kishida H., Takeuchi E., Tadokoro M., Uchikoshi T., Oikawa K. Studies on the delayed neurotoxicity of organophosphorus compounds. III. J. Toxicol. Sci. 1985, 10:67-82.
120. Jensen K.F., Lapadula D.M., Anderson J.K., Haykal-Coates N., Abou-Donia M.B. Anomalous phosphorylated neurofilament aggregations in central and peripheral axons of hens treated with tri-ortho-cresyl phosphate (TOCP). J. Neurosci. Res. 1992, 33:455-460.
121. Johnson M.K. Structure-activity relationships for substrates and inhibitors of hen brain neurotoxic esterase. Biochem. Pharmacol. 1975, 24:797-805.
122. Johnson M.K. The target for initiation of delayed neurotoxicity by organophosphorus esters: Biochemical studies and toxicological application. "Reviews in Biochemical Toxicology" 1982, Vol. 4:141-212. Elsevier Biomedical, New York. E. Hodgson, J.R. Bond, R.M. Philpot (Eds.).
123. Johnson M.K. Molecular events in delayed neuropathy: Experimental aspects of neuropathy target esterase. Clinical and Experimental Toxicology of Organophosphates and Carbamates 1992, 90-113. Butterworth-Heinemann, Oxford. B. Ballantyne, T.C. Marrs (Eds.).
124. Johnson M.K., Glynn P. Neuropathy target esterase. Handbook of Pesticide Toxicology 2001, 953-965. Academic Press, San Diego. R. Krieger (Ed.).
125. Johnson M.K., Read D.J. The influence of chirality on the delayed neuropathic potential of some organophosphorus esters: Neuropathic and prophylactic effects of stereoisomeric esters of ethyl phenylphosphonic acid (EPN oxon and EPN) correlate with quantities of aged and unaged neuropathy target esterase in vivo. Toxicol. Appl. Pharmacol. 1987, 90:103-115.
126. Johnson M.K., Read D.J. Prophylaxis against and promotion of organophosphate-induced delayed neuropathy by phenyl di-n-pentylphosphinate. Chem. Biol. Interact. 1993, 87:449-455.
127. Johnson M.K., Vilanova E., Read D.J. Anomalous biochemical responses in tests of the delayed neuropathic potential of methamidophos (O,S-dimethyl phosphorothioamidate), its resolved isomers and of some higher O-alkyl homologues. Arch. Toxicol. 1991, 65:618-624.
128. Jortner B.S. Pathology of organophosphorus-induced delayed neurotoxicity. "14th Conference on Environmental Toxicology" 1984, 106-117. National Technical Information Service, Springfield, VA.
129. Jortner B.S. Organophosphorus ester-induced delayed neuropathy, rat. Monographs on Pathology of Laboratory Animals-Nervous System 1988, 41-47. Springer-Verlag, New York. T.C. Jones, U. Mohr, R.D. Hunt (Eds.).
130. Jortner B.S., Ehrich M. Neuropathological effects of phenyl saligenin phosphate in chickens. Neurotoxicology 1987, 8:303-314.
131. Jortner B.S., Pope AM., Heavner J.E. Haloxon-induced delayed neurotoxicity: Effect of plasma A (aryl) esterase activity on severity of lesions in sheep. Neurotoxicology 1983, 4:241-246.
132. Jortner B.S., Shell L., El-Fawal H., Ehrich M. Myelinated nerve fiber regeneration following organophosphorus ester-induced delayed neuropathy. Neurotoxicology 1989, 10:717-726.
133. Jortner B.S., Perkins S.K., Ehrich M. Immunohistochemical study of phosphorylated neurofilaments during the evolution of organophosphorus ester-induced delayed neuropathy (OPIDN). Neurotoxicology 1999, 20:971-976.
134. Jortner B.S., Hancock S.K., Hinckley J., Flory L., Colby L., Tobias L., Williams L., Ehrich M. Neuropathological studies of rats following multiple exposure to tri-ortho-tolyl phosphate, chlorpyrifos and stress. Toxicol. Pathol. 2005, 33:378-385.
135. Kidd J.G., Langworthy O.R. Jake paralysis: Paralysis following the ingestion of Jamaica ginger extract adulterated with tri-ortho-cresyl phosphate. Bull. Johns Hopkins Hosp. 1933, 52:39-65.
136. Knoth-Anderson J., Abou-Donia M.B. Differential effects of triphenylphosphite and diisopropyl phosphorofluoridate on catecholamine secretion from bovine adrenomedullary chromaffin cells. J. Toxicol. Environ. Health 1993, 38:103-114.
137. Knoth-Anderson J., Veronesi B., Jones K., Lapadula D.M., Abou-Donia M.B. Triphenyl phosphite-induced ultrastructural changes in bovine adrenomedullary chromaffin cells. Toxicol. Appl. Pharmacol. 1992, 112:110-119.
138. Krinke G., Ullmann L., Sachsee K., Hess R. Differential susceptibility of peripheral nerves of the hen to tri-ortho-cresyl phosphate and to trauma. Agents Actions 1979, 9:227-231.
139. Kretzschmar D. Neurodegenerative mutants in Drosophila: A means to identify genes and mechanisms involved in human diseases?. Invert. Neurosci. 2005, 5:97-109.
140. Kropp T.J., Richardson R.J. Relative inhibitory potencies of chlorpyrifos oxon, chlorpyrifos methyl oxon, and mipafox for acetylcholinesterase versus neuropathy target esterase. J. Toxicol. Environ. Health 2003, 66A:1145-1157.
141. Kropp T.J., Glynn P., Richardson R.J. The mipafox-inhibited catalytic domain of human neuropathy target esterase ages by reversible protein loss. Biochemistry 2004, 30:3716-3722.
142. Lapadula D.M., Kinnes C.G., Somjen G.G., Abou-Donia M.B. Monosynaptic reflex depression in cats with organophosphorus neuropathy: Effects of tri-O-cresyl phosphate. Neurotoxicology 1982, 3:51-61.
143. Lapadula D.M., Patton S.E., Campbell G.A., Abou-Donia M.B. Characterization of delayed neurotoxicity in the mouse following chronic oral administration of tri-o-cresyl phosphate. Toxicol. Appl. Pharmacol. 1985, 79:83-90.
144. Lapadula E.S., Lapadula D.M., Abou-Donia M.B. Persistent alterations of calmodulin kinase II activity in chickens after an oral dose of tri-o-cresyl phosphate. Biochem. Pharmacol. 1991, 42:171-180.
145. Lapadula E.S., Lapadula D.M., Abou-Donia M.B. Biochemical changes in sciatic nerve of hens treated with tri-o-cresyl phosphate: Increased phosphorylation of cytoskeletal proteins. Neurochem. Int. 1992, 20:247-255.
146. Larsen C., Jortner B.S., Ehrich M. Effect of neurotoxic organophosphorus compounds in turkeys. J. Toxicol. Environ. Health 1986, 17:365-374.
147. Lehning E.J., Tanaka D., Bursian S.J. Triphenyl phosphite and diisopropylphosphorofluoridate produce separate and distinct axonal degeneration patterns in the central nervous system of the rat. Fundam. Appl. Toxicol. 1996, 29:110-118.
148. LeVay S., Meier C., Glees P. Effects of tri-ortho-cresyl-phosphate on spinal ganglia and nerves of chickens. Acta Neuropathol. 1971, 17:103-113.
149. Li W., Casida J.E. Actions of two highly potent organophosphorus neuropathy target esterase inhibitors in mammalian cell lines. Toxicol. Lett. 1997, 92:123-130.
150. Li Y., Dinsdale D., Glynn P. Protein domains, catalytic activity, and subcellular distribution of neuropathy target esterase in mammalian cells. J. Biol. Chem. 2003, 278:8820-8825.
151. Lidsky T.I., Manetto C., Ehrich M. Nerve conduction studies in chickens given phenyl saligenin phosphate and corticosterone. J. Toxicol. Environ. Health 1990, 29:65-75.
152. Lotti M. The pathogenesis of organophosphate polyneuropathy. Crit. Rev. Toxicol. 1992, 21:465-488.
153. Lotti M. The concept and target of promotion of axonopathies. Arch. Toxicol. Suppl. 1997, 19:331-336.
154. Lotti M. Clinical toxicology of anticholinesterase agents in humans. Handbook of Pesticide Toxicology 2001, 1043-1086. Academic Press, San Diego. R. Krieger, (Ed.).
155. Lotti M. Promotion of organophosphate induced delayed polyneuropathy by certain esterase inhibitors. Toxicology 2002, 181/182:245-248.
156. Lotti M., Moretto A. Promotion of organophosphate induced polyneuropathy by certain esterase inhibitors. Chem. Biol. Interact. 1999, 119-120:513-518.
157. Lotti M., Moretto A. Organophosphate-induced delayed polyneuropathy. Toxicol. Rev. 2005, 24:37-49.
158. Lotti M., Moretto A. Do carbamates cause polyneuropathy?. Muscle Nerve 2006, 34:499-502.
159. Lotti M., Moretto A., Capodicasa E., Bertolazzi M., Peraica M., Scapellato M.L. Interactions between neuropathy target esterase and its inhibitors and the development of polyneuropathy. Toxicol. Appl. Pharmacol. 1993, 122:165-171.
160. Lotti M., Moretto A., Bertolazzi M., Peraica M., Fioroni F. Organophosphate polyneuropathy and neuropathy target esterase: Studies with methamidophos and its resolved optical isomers. Arch. Toxicol. 1995, 69:330-336.
161. Lush M.J., Li Y., Read D.J., Willis A.C., Glynn P. Neuropathy target esterase and a homologous Drosophila neurodegeneration-associated mutant protein contain a novel domain conserved from bacteria to man. Biochem. J. 1998, 332:1-4.
162. Mackay C.E., Hammock B.D., Wilson B.W. Identification and isolation of a 155-kDa protein with neuropathy target esterase activity. Fundam. Appl. Toxicol. 1996, 30:23-30.
163. Makhaeva G.F., Malygin V.V., Strakhova N.N., Sigolaeva L.V., Sokolovskaya L.G., Eremenko A.V., Kurochkin I.N., Richardson R.J. Biosensor assay of neuropathy target esterase in whole blood as a new approach to OPIDN risk assessment: review of progress. Hum. Exp. Toxicol. 2007, 26:273-282.
164. Malygin V.V., Sokolov V.B., Richardson R.J., Makhaeva G.F. Quantitative structure-activity relationships predict the delayed neurotoxicity potential of a series of O-alkyl-O-methylchloroformimino phenylphosphonates. J. Toxicol. Environ Health 2003, 66A:611-625.
165. Maroni M., Bleecker M.L. Neuropathy target esterase in human lymphocytes and platelets. J. Appl. Toxicol. 1986, 6:1-7.
166. Massicotte C., Dyer Inzana K., Ehrich M., Jortner B.S. Neuropathologic effects of phenylmethylsulfonyl fluoride (PMSF)-induced promotion and protection in organophosphorus ester-induced delayed neuropathy (OPIDN) in hens. Neurotoxicology 1999, 20:729-760.
167. Massicotte C., Barber D.S., Jortner B.S., Ehrich M. Nerve conduction velocity and ATP concentrations in sciatic-tibial and medial plantar nerves of hens given phenyl saligenin phosphate. Neurotoxicology 2001, 22:91-98.
168. Massicotte C., Jortner B.S., Ehrich M. Morphological effects of neuropathy-inducing organophosphorus compounds in primary dorsal root ganglia cell cultures. Neurotoxicology 2003, 24:787-796.
169. Massicotte C., Knight K., Van der Schyf C.J., Jortner B.S., Ehrich M. Effects of organophosphorus compounds on ATP production and mitochondrial integrity in cultured cells. Neurotoxicity Res. 2005, 7:203-217.
170. McCain W.C., Lee J.C., Wilcke J.R., Ehrich M. The effect of phenyl saligenin phosphate induced delayed neuropathy on selected hemodynamic and hematologic parameters in the hen. Pestic. Biochem. Physiol. 1993, 45:220-227.
171. McCain W.C., Wilcke J., Lee J.C., Ehrich M. Effect of cyclic phenyl saligenin phosphate and paraoxon treatment on vascular response to adrenergic and cholinergic agents in hens. J. Toxicol. Environ. Health 1995, 44:167-187.
172. McEwan B.S. The neurobiology of stress: from serendipity to clinical relevance. Brain Res. 2000, 886:172-189.
173. Moretto A., Lotti M., Sabri M.I., Spencer P.S. Progressive deficit of retrograde axonal transport is associated with the pathogenesis of di-n-butyl dichlorvos axonopathy. J. Neurochem. 1987, 49:1515-1522.
174. Moretto A., Capodicasa E., Peraica M., Lotti M. Age sensitivity to organophosphate-induced delayed polyneuropathy: Biochemical and toxicological studies in developing chicks. Biochem. Pharmacol. 1991, 41:1497-1504.
175. Moretto A., Bertolazzi M., Capodicasa E., Peraica M., Richardson R.J., Scapellato M.L., Lotti M. Phenylmethanesulfonyl fluoride elicits and intensifies the clinical expression of neuropathic insults. Arch. Toxicol. 1992, 66:67-72.
176. Moretto A., Capodicasa E., Lotti M. Clinical expression of organophosphate-induced delayed polyneuropathy in rats. Toxicol. Lett. 1992, 63:97-102. [Erratum Toxicol. Lett. 1992; 63, 355].
177. Moretto A., Nicoli A., Lotti M. Peripheral nerve esterases and the promotion of organophosphate-induced neuropathy in hens. Chem. Biol. Interact. 2005, 157/158:285-291.
178. Moser M., Li Y., Vaupel K., Kretzschmar D., Kluge R., Glynn P., Beuttner R. Placental failure and impaired vasculogenesis result in embryonic lethality for neuropathy target esterase-deficient mice. Mol. Cell Biol. 2004, 24:1667-1679.
179. Moser V.C., Aschner M., Richardson R.J., Philbert M.A. Toxic responses of the nervous system. Casarett & Doull's Toxicology the Basic Science of Poisons 2008, 631-664. McGraw-Hill, New York. 7th ed. C.D. Klaassen, (Ed.).
180. Muhlig-Versen J.M., Bettencourt da Cruz A., Tsachape J.D., Moser M., Buttner R., Athenstaedt K., Glynn P., Kretzschmar D. Loss of Swiss cheese/neuropathy target esterase activity causes disruption of phosphatidylcholine homeostasis and neuronal and glial death in adult Drosophila. J. Neurosci. 2005, 25:2865-2873.
181. Muzardo G.A., Machado R.G.P., Honorato de Oliveira G. Effects of calcium gluconate and PMSF in the treatment of acute intoxication of chicken by TOCP. Hum. Exp. Toxicol. 2008, 27:247-252.
182. Nostrandt A.C., Ehrich M. Development of a model cell culture system in which to study early effects of neuropathy-inducing organophosphorus esters. Toxicol. Lett. 1992, 60:107-114.
183. Nostrandt A.C., Ehrich M. Modification of mipafox-induced inhibition of neuropathy target esterase in neuroblastoma cells of human origin. Toxicol. Appl. Pharmacol. 1993, 121:36-42.
184. O'Callaghan J.P. Neurotoxic esterase: not so toxic?. Nature Genet. 2003, 33:1-2.
185. Osman K.A., Moretto A., Lotti M. Sulfonyl fluorides and the promotion of diisopropyl fluorophosphate neuropathy. Fundam. Appl. Toxicol. 1996, 33:294-297.
186. Padilla S., Veronesi B. The relationship between neurological damage and neurotoxic esterase inhibition in rats acutely exposed to tri-ortho-tolyl phosphate. Toxicol. Appl. Pharmacol. 1985, 78:78-87.
187. Padilla S., Veronesi B. Biochemical and morphological validation of a rodent model for organophosphorus-induced delayed neuropathy. Toxicol. Ind. Health 1988, 4:331-337.
188. Patton S.E., Lapadula D.M., O'Callaghan J.P., Miller D.B., Abou-Donia M.B. Changes in in vitro brain and spinal cord protein phosphorylation after a single oral administration of tri-o-cresyl phosphate to hens. J. Neurochem. 1985, 45:1567-1572.
189. Peraica M., Capodicasa E., Moretto A., Lotti M. Organophosphate polyneuropathy in chicks. Biochem. Pharmacol. 1993, 45:131-135.
190. Perdrizet J.A., Cummings J.E., Lahunta A. Presumptive organophosphate-induced delayed neurotoxicity in a paralyzed bull. Cornell Veterinarian 1985, 75:401-410.
191. Piao F., Yamauchi T., Ma N. The effect of Calcicol as calcium tonic on delayed neurotoxicity induced by organophosphorus compounds. Toxicol. Lett. 2003, 143:65-71.
192. Piao F., Ma N., Yamamoto H., Yamauchi T., Yokoyama K. Effect of prednisolone and complex of vitamin B1, B2, B6 and B12 on organophosphorus compound-induced delayed neurotoxicity. J. Occup. Health 2004, 46:359-364.
193. Pomeroy-Black M., Jortner B.S., Ehrich M. Early effects of neuropathy-inducing organophosphates on in vivo concentrations of three neurotrophins. Neurotox. Res. 2007, 11:85-91.
194. Pope C., diLorenzo K., Ehrich M. Possible involvement of a neurotrophic factor during the early stages of organophosphate-induced delayed neurotoxicity. Toxicol. Lett. 1995, 75:111-117.
195. Pope C.N., Padilla S. Potentiation of organophosphorus-induced delayed neurotoxicity by phenylmethylsulfonyl fluoride. J. Toxicol. Environ. Health 1990, 31:261-273.
196. Pope C.N., Chapman M.L., Tanaka D., Padilla S. Phenylmethylsulfonyl fluoride alters sensitivity to organophosphorus-induced delayed neurotoxicity in developing animals. Neurotoxicology 1992, 13:355-364.
197. Pope C.N., Tanaka D., Padilla S. The role of neurotoxic esterase (NTE) in the prevention and potentiation of organophosphorus-induced delayed neurotoxicity (OPIDN). Chem. Biol. Interact. 1993, 87:395-406.
198. Prineas J. The pathogenesis of dying-back polyneuropathies: 1. An ultrastructural study of experimental tri-ortho-cresyl phosphate intoxication in the cat. J. Neuropathol. Exp. Neurol. 1969, 28:571-597.
199. Qian Y., Venkatraj J., Barhoumi R., Pal R., Datta S., Wild J.R., Tiffany-Castiglioni E. Comparative non-cholinergic neurotoxic effects of paraoxon and diisopropyl fluorophosphates (DFP) on human neuroblastoma and astrocytoma cell lines. Toxicol. Appl. Pharmacol. 2007, 291:162-171.
200. Quesada E., Castell J.V., Vilanova E., Carrera V. Over-expression of neuropathy target esterase activity in bovine chromaffin cell cultures by adenovirus-mediated gene transfer. Toxicol. Lett. 2007, 168:286-291.
201. Quistad G.B., Barlow C., Winrow C.J., Sparks S.E., Casida J.E. Evidence that mouse brain neuropathy target esterase is a lysophospholipase. Proc. Nat. Acad. Sci. USA 2003, 100:7983-7987.
202. Rainier S., Bui M., Mark E., Thomas D., Tokarz D., Ming L., Delaney C., Richardson R.J., Albers J.W., Matsunami N., Stevens J., Coon H., Leppert M., Fink J.K. Neuropathy target esterase gene mutations cause motor neuron disease. Am. J. Hum. Genet. 2008, 83:780-785.
203. Randall J.C., Yano B.L., Richardson R.J. Potentiation of organophosphorus compound-induced delayed neurotoxicity (OPIDN) in the central and peripheral nervous system of the adult hen: Distribution of axonal lesions. J. Toxicol. Environ. Health 1997, 51:571-590.
204. Read D.J., Langford L., Barbour H.R., Forshaw P.J., Glynn P. Phospholipase B activity and organophosphorus compound toxicity in cultured neural cells. Toxicol. Appl. Pharmacol. 2007, 219:190-195.
205. Richardson R.J. Assessment of the neurotoxic potential of chlorpyrifos relative to other organophosphorus compounds: A critical review of the literature. J. Toxicol. Environ. Health 1995, 44:135-165.
206. Roberts D.V. A longitudinal electromyographical study of six men occupationally exposed to organophosphorus compounds. Int. Arch. Occup. Environ. Health 1977, 38:221-229.
207. Robertson D.G., Schwab B.W., Sills R.D., Richardson R.J., Anderson R.J. Electrophysiologic changes following treatment with organophosphorus-induced delayed neuropathy-producing agents in the adult hen. Toxicol. Appl. Pharmacol. 1987, 87:420-429.
208. Robertson D.G., Mattson A.M., Bestervelt L.L., Richardson R.J., Anderson R.J. Time course of electrophysiologic effects induced by di-n-butyl-2,2-dichlorovinyl phosphate (DBCVP) in the adult hen. J. Toxicol. Environ. Health 1988, 23:283-294.
209. Sales K.M., Kingston S.T., Doyle K.M., Purcell W.M. Preliminary characterisation of an in vitro paradigm for the study of the delayed effects of organophosphorus compounds: hen embryo brain spheroids. Toxicology 2004, 195:187-202.
210. Sanders D.E., Lahunta D.E., Cummings J.F., Sanders J.A. Progressive paresis in sheep due to delayed neurotoxicity of triaryl phosphates. Cornell Veterinarian 1985, 75:493-504.
211. Schaeppi U., Krinke G., Kobel W. Prolonged exposure to triethylphosphate induces sensory motor neuropathy in the dog. Neurobehav. Toxicol. Teratol. 1984, 6:39-50.
212. Schlaepfer W.W., Hasler M.B. Characterization of the calcium-induced disruption of neurofilaments in rat peripheral nerve. Brain Res. 1979, 168:299-309.
213. Schlaepfer W.W., Zimmerman U.P. Calcium activated protease and the regulation of the axonal cytoskeleton. Axonal Transport in Neuronal Growth and Regeneration 1984, 261-273. Plenum, New York. J.S. Elam, P. Cancalon (Eds.).
214. Shell L., Jortner B.S., Ehrich M. Assessment of organophosphorus-induced delayed neuropathy in chickens using needle electromyography. J. Toxicol. Environ. Health 1988, 25:21-33.
215. Sogorb M.A., Bas S., Gutierrez L.M., Vilanova E., Viniegra S. Bovine chromaffin cells as an in vitro model for the study of non-cholinergic toxic effects of organophosphorus compounds. Arch. Toxicol. Suppl. 1997, 19:347-355.
216. Somkuti S.G., Tilson H.A., Brown H.R., Campbell G.A., Lapadula D.M., Abou-Donia M.B. Lack of delayed neurotoxic effect after tri-o-cresyl phosphate treatment in male Fischer 344 rats: Biochemical, neurobehavioral, and neuropathological studies. Fundam. Appl. Toxicol. 1988, 10:199-205.
217. Song F., Yan Y., Zhao X., Zhang C., Xie K. Neurofilaments degradation as an early molecular event in tri-ortho-cresyl phosphate (TOCP) induced delayed neuropathy. Toxicology 2009, 258:94-100.
218. Stumpf A.M., Tanaka D.J., Aulerich R.J., Bursian S.J. Delayed neurotoxic effects of tri-o-tolyl phosphate in the European ferret. J. Toxicol. Environ. Health 1989, 26:61-73.
219. Suwita E., Lapadula D.M., Abou-Donia M.B. Calcium and calmodulin stimulated in vitro phosphorylation of rooster brain tubulin and MAP-2 following a single oral dose of tri-o-cresyl phosphate. Brain Res. 1986, 374:199-203.
220. Suwita E., Lapadula D.M., Abou-Donia M.B. Calcium and calmodulin-enhanced in vitro phosphorylation of hen brain cold-stable microtubules and spinal cord neurofilament triplet proteins after a single oral dose of tri-o-cresyl phosphate. Proc. Natl. Acad. Sci. USA 1986, 83:6174-6178.
221. Tanaka D.J., Bursian S.J. Degeneration patterns in the chicken central nervous system induced by ingestion of the organophosphorus delayed neurotoxin tri-ortho-tolyl phosphate: A silver impregnation study. Brain Res. 1989, 484:240-256.
222. Tanaka D., Bursian S.J., Lehning E. Selective and terminal degeneration in the chicken brainstem and cerebellum following exposure to bi(1-methylethyl)phosphorofluoridate (DFP). Brain Res. 1990, 519:200-208.
223. Tanaka D., Bursian S.J., Lehning E.J. Neuropathological effects of triphenyl phosphite on the central nervous system of the hen. Fundam. Appl. Toxicol. 1992, 18:72-78.
224. Tanaka D.J., Bursian S.J., Lehning E.J., Auterich R.J. Delayed neurotoxic effects of bis(1-methylethyl) phosphorofluoridate (DFP) in the European ferret: A possible mammalian model for organophosphorus-induced delayed neurotoxicity. Neurotoxicology 1991, 12:209-224.
225. Thomas T.C., Szekacs A., Hammock B.D., Wilson B.W., McNamee MG. Affinity chromatography of neuropathy target esterase. Chem. Biol. Interact. 1993, 87:347-360.
226. U.S. Environmental Protection Agency (EPA) (1996). "Health Effects Test Guidelines OPPTS 870.6100. Delayed Neurotoxicity of Organophosphorus Substances Following Acute and 28-Day Exposure." Available at http://www.epa.gov/opptsfrs/publications/OPPTS_Harmonized/870_Health_Eff ects_Test_Guidelines/Drafts/870-6100.pdf.
227. Varghese R.G., Bursian S.J., Tobias C., Tanaka D. Organophosphorus-induced delayed neurotoxicity: A comparative study of the effects of tri-ortho-tolyl phosphate and triphenyl phosphite on the central nervous system of the Japanese quail. Neurotoxicology 1995, 16:45-54.
228. Vasilescu C., Alexianu M., Dan A. Delayed neuropathy after organophosphorus insecticide (Diperterex) poisoning: A clinical, electrophysiological and nerve biopsy study. J. Neurol. Neurosurg. Neuropsychol. 1984, 47:543-548.
229. Veronesi B. Effect of metabolic inhibition with piperonyl butoxide on rodent sensitivity to tri-ortho-cresyl phosphate. Exp. Neurol. 1984, 85:651-660.
230. Veronesi B., Dvergsten C. Triphenyl phosphite neuropathy differs from organophosphorus-induced delayed neuropathy in rats. Neuropathol. Appl. Neurobiol. 1987, 13:193-208.
231. Veronesi B., Padilla S., Lyerly D. The correlation between neurotoxic esterase inhibition and mipafox-induced damage in rats. Neurotoxicology 1986, 7:207-216.
232. Veronesi B., Padilla S., Blackmon K., Pope C. Murine susceptibility to organophosphorus-induced delayed neuropathy (OPIDN). Toxicol. Appl. Pharmacol. 1991, 107:311-324.
233. Vose S.C., Holland N.T., Eskenazi B., Casida J.E. Lysophosphatidylcholine hydrolases of human erythrocytes, lymphocytes, and brain: Sensitive targets of conserved specificity for organophosphorus delayed neurotoxicants. Toxicol. Appl. Pharmacol. 2007, 224:98-104.
234. Vose S.C., Fujioka K., Gulevich A.G., Lin A.Y., Holland N.T., Casida J.E. Cellular function of neuropathy target esterase in lysophosphatidylcholine action. Toxicol. Appl. Pharmacol. 2008, 232:376-383.
235. Wijeyesakere S.J., Richardson R.J., Stuckey J.A. Modeling the tertiary structure of the patatin domain of neuropathy target esterase. Protein J. 2007, 26:165-172.
236. Wilkinson I.M.S. Essential Neurology 1993, Blackwell, Oxford.
237. Winrow C.J., Hemming M.L., Allen D.M., Quistad G.B., Casida J.E., Barlow C. Loss of neuropathy target esterase in mice links organophosphate exposure to hyperactivity. Nature Genet. 2003, 33:477-485.
238. Wu S.Y., Casida J.E. Neuropathy target esterase inhibitors: Enantiomeric separation and stereospecificity of 2-substituted-4H-1,3,2-benzodioxaphosphorin 2 oxides. Chem. Res. Toxicol. 1994, 7:77-81.
239. Wu S.Y., Casida J.E. Ethyl octylphosphonofluoridate and analogs: Optimized inhibitors of neuropathy target esterase. Chem. Res. Toxicol. 1995, 8:1070-1075.
240. Wu S.Y., Casida J.E. Subacute neurotoxicity induced in mice by potent organophosphorus neuropathy target esterase inhibitors. Toxicol. Appl. Pharmacol. 1996, 139:195-202.
241. Yoshida M., Wu S.Y., Casida J.E. Reactivity and stereospecificity of neuropathy target esterase and a-chymotrypsin with 2-substituted-4H-1,3,2-benzodioxaphosphorin 2 oxides. Toxicol. Lett. 1994, 74:164-176.
242. 3H]benzodioxaphosphorin 2 oxide. J. Neurochem. 1995, 64:1680-1687.
243. Zaccheo O., Dinsdale D., Meacock P.A., Glynn P. Neuropathy target esterase and its yeast homologue degrade phosphatidylcholine to glycerophosphocholine in living cells. J. Biol. Chem. 2004, 279:24024-24033.
244. Zhao X.L., Zhang T.L., Zhang C.L., Han X.Y., Yu S.F., Li S.X., Cui N., Xie K.Q. Expression changes of neurofilament subunits in the central nervous system of hens treated with tri-ortho-cresyl phosphate (TOCP). Toxicology 2006, 223:127-135.